| # | Drug | Count |
|---|---|---|
| 0 | HYDRALAZINE HYDROCHLORIDE | 433 |
| 1 | PREDNISONE | 214 |
| 2 | RITUXIMAB | 193 |
| 3 | AMLODIPINE | 174 |
| 4 | CYCLOPHOSPHAMIDE | 159 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 159 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 159 |
| 7 | METOPROLOL TARTRATE | 134 |
| 8 | FUROSEMIDE | 128 |
| 9 | METOPROLOL | 126 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDRALAZINE HYDROCHLORIDE | 433 | 0.1619 |
| 1 | PENICILLAMINE | 56 | 0.0604 |
| 2 | AMCINONIDE | 4 | 0.0471 |
| 3 | PROPYLTHIOURACIL | 87 | 0.0418 |
| 4 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | 4 | 0.0111 |
| 5 | CLEVIDIPINE | 4 | 0.0109 |
| 6 | AVACOPAN | 73 | 0.0108 |
| 7 | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | 4 | 0.0101 |
| 8 | GOLD | 50 | 0.0086 |
| 9 | CHLORZOXAZONE | 11 | 0.0083 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 358 |
| 1 | Dihydropyridine Calcium Channel Blocker [EPC] | 217 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 209 |
| 3 | Calcium Channel Blocker [EPC] | 174 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 171 |
| 5 | Alkylating Drug [EPC] | 159 |
| 6 | beta-Adrenergic Blocker [EPC] | 154 |
| 7 | Loop Diuretic [EPC] | 152 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 121 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 117 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 8 | 0.0116 |
| 1 | Thyroid Hormone Synthesis Inhibitor [EPC] | 109 | 0.0112 |
| 2 | Complement 5a Receptor Antagonist [EPC] | 73 | 0.0108 |
| 3 | Humanized Monoclonal Antibody Fragment [EPC] | 5 | 0.0035 |
| 4 | Classical Complement Pathway Inhibitor [EPC] | 1 | 0.0031 |
| 5 | Interleukin-1 Receptor Antagonist [EPC] | 33 | 0.0020 |
| 6 | Selective T Cell Costimulation Blocker [EPC] | 9 | 0.0019 |
| 7 | alpha-Hydroxy Acid [EPC] | 4 | 0.0018 |
| 8 | Central alpha-2 Adrenergic Agonist [EPC] | 73 | 0.0014 |
| 9 | Aminoglycoside Antibacterial [EPC] | 51 | 0.0011 |